asthma drugs Flashcards

1
Q

what are the first line therapy drug treatments for asthma?

A

glucocorticoids (steroids) and bronchodilators (e.g. b2 adrenergic agonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is chronic asthma;

A

recurrent attacks of reversible airway obstruction of air flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

function of the airways?

A

to carry oxygen and carbon dioxide between the alveoli in the lungs and the air (mouth)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what happens to the airways during asthma?

A

they become constricted due to inflammation, muscle contraction or excessive mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

features of asthma?

A

characterised by inflammation of the airways and hyper-reactivity of the bronchioles, resulting in bronchoconstriction and mucus secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

aim of asthma drug treatments?

A

to reduce inflammation, prevent bronchoconstriction and restore airways calibre to normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

stimuli that may trigger an asthma attack?

A

exercise and cold air, respiratory infection, atmospheric pollutants, allergens in sensitised people; pollen, dust mite proteins and animal dander

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does asthma develop?

A

when allergen is presented, B cells are activated via the T cell cascade to produce IgE’s which recognise the antigen. high affinity binding of IgE’s and mast cells occurs resulting in inflammatory cell recruitment and bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the immediate/early phase of asthma attack?

A

bronchospasm: bronchial muscle contracts causing mast cells to release spasmogens. mast cells then release inflammatory mediators such as interleukins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the late phase of asthma attack?

A

progressing inflammatory reaction; Th2 lymphocytes and eosinophils invade and there is a release of cytokines, chemokines and toxic proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what can agents of inflammatory mediators cause?

A

damage to and loss of bronchial epithelium, smooth muscle cell hypertrophy and hyperplasia and hyper-reactivity to irritant stimuli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

examples of bronchodilator drugs?

A

B2 adrenergic receptor agonists, theophylline, muscarinic receptor antagonists, leukotriene receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

function of bronchodilators?

A

dilate bronchioles and increase air flow to the alveoli, relax smooth muscle cells around walls of bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

action of B2 adrenergic receptor agonists?

A

act on B2 adrenoceptors on bronchiole smooth muscle to relax muscle; inhibit mediator release from mast cells and monocytes; act on cilia to increase mucus clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe SHORT acting B2 adrenergic receptor agonists?

A

salbutamol, terbutaline - max effect occurs in 30 mins, lasts 4-6 hours. used as needed to control asthma symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe long acting B2 adrenergic receptor agonists?

A

salmeterol - duration of action is 12 hours, used 2x daily

17
Q

side effects of B2 adrenergic receptor agonists?

A

tremor, some tolerance may develop

18
Q

why is theophylline administered?

A

used with steroids when asthma response to B2 agonists is inadequate. e.g. xanthine

19
Q

unwanted effects of theophylline?

A

stimulates the CNS causing tremor and sleep disturbance, stimulates the heart and causes vasodilation, GI effects such as anorexia, nausea and vomiting

20
Q

actions of muscarinic receptor antagonists?

A

relax bronchial smooth muscle, inhibit elevated mucus secretion, increase clearance of bronchial secretions, block action of endogenous acetylcholine at muscarinic receptors

21
Q

example of a muscarinic receptor antagonist?

A

ipratropium

22
Q

examples of leukotriene receptor antagonists?

A

montelukast (1x day) zafirlukast (2x day)

23
Q

unwanted effects of leukotriene receptor antagonists?

A

headache, GI disturbance

24
Q

action of leukotriene receptor antagonists?

A

used as an add-on with B2 agonists, work against exercise-induced and aspirin sensitive asthma

25
Q

examples of glucocorticoids (anti-inflammatory drugs):

A

beclomethasone, diproprionate, budesonide, fluticasone, propionate, prednisolone, hydrocortisone

26
Q

action of glucocorticoids?

A

reduce production of cytokines, spasmogens, and leucocyte chemotaxins to reduce bronchospasm and the recruitment and activation of inflammatory cells

27
Q

unwanted effects of glucocorticoids?

A

inhaled steroids; oropharyngeal thrush, dysphonia. oral; adrenal suppression - patients must carry steroid card

28
Q

action of cromoglicate?

A

reduce early and late phase responses in asthma, reduces bronchial hyper-sensitivity, stabilises mast cells

29
Q

unwanted effects of cromoglicate ?

A

irritation of upper respiratory tract, hypersensitivity reactions

30
Q

what is omalizumab?

A

a biologic agent, a recombinant DNA-derived humanized IgG1 monoclonal antibody

31
Q

action of omalizumab?

A

binds to human IgE and inhibits binding of IgE to IgE receptor on mast cells, inhibiting IgE-mediated cascade of asthma

32
Q

unwanted effects of omalizumab?

A

anaphylaxis, malignancies

33
Q

which asthma treatment should be used for mild asthma with rare attacks?

A

inhaled B2 agonist when required

34
Q

which asthma treatment should be used for mild asthma with frequent attacks?

A

glucocorticoid for prophylaxis, B2 agonist when needed for acute attacks

35
Q

which asthma treatment should be used for moderate to severe asthma?

A

drug combination; B2 agonist with glucocorticoid in combined inhaler